» Articles » PMID: 21131430

Symptom Experience of Pulmonary Arterial Hypertension Patients

Overview
Journal Clin Nurs Res
Specialty Nursing
Date 2010 Dec 7
PMID 21131430
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To describe symptoms experienced by pulmonary arterial hypertension (PAH) patients and the impact these symptoms have had on their lives.

Method: Qualitative descriptive methodology was chosen incorporating semistructured interviews to investigate the symptom experience of ten patients with PAH.

Results: All patients were diagnosed with WHO Group 1 PAH and 70% were WHO functional Class III. Two overarching themes emerged: holding back and redefining life. Holding back was represented by three subthemes: fear, anticipation of worsening symptoms, and treatment effects. Redefining life was characterized by uncertainty, activity restrictions, and making the best of it.

Conclusion: This study revealed specific concerns related to the symptom experience of PAH patients and how they redefined their lives to accommodate these symptoms. These findings provide a basis for larger, quantitative studies to examine the extent of symptom impact as well as a framework for development of self management interventions to improve the symptom experience and QOL.

Citing Articles

Sleep Quality and Its Predictors among Dyspnea, Fatigue and Exercise Capacity in Pulmonary Arterial Hypertension.

Ceylan R, Demir R, Zeren M, Sinan U, Kucukoglu M Acta Cardiol Sin. 2024; 40(5):618-626.

PMID: 39308648 PMC: 11413941. DOI: 10.6515/ACS.202409_40(5).20240712A.


'Fear, uncertain, tired…...' psychological distress among pulmonary hypertension patients: a qualitative interview study.

Zhang J, Zhang Y, Yin Y, Feng Y, Zhang R, Meng H BMC Psychiatry. 2024; 24(1):100.

PMID: 38317081 PMC: 10840283. DOI: 10.1186/s12888-024-05539-z.


The economic burden of pulmonary arterial hypertension in Spain.

Zozaya N, Abdalla F, Casado Moreno I, Crespo-Diz C, Ramirez Gallardo A, Rueda Soriano J BMC Pulm Med. 2022; 22(1):105.

PMID: 35346140 PMC: 8962538. DOI: 10.1186/s12890-022-01906-2.


Respiratory rate modulation improves symptoms in patients with pulmonary hypertension.

Kjellstrom B, Ivarsson B, Landenfelt Gestre L, Ryftenius H, Nisell M SAGE Open Med. 2021; 9:20503121211053930.

PMID: 34733511 PMC: 8558785. DOI: 10.1177/20503121211053930.


Physical Activity and Mental Health of Patients with Pulmonary Hypertension during the COVID-19 Pandemic.

Dobler C, Kruger B, Strahler J, Weyh C, Gebhardt K, Tello K J Clin Med. 2020; 9(12).

PMID: 33322755 PMC: 7763755. DOI: 10.3390/jcm9124023.